{"pmid":32339394,"title":"Measuring weight with e-scales in clinical and research settings during the COVID-19 pandemic.","text":["Measuring weight with e-scales in clinical and research settings during the COVID-19 pandemic.","With the COVID-19 pandemic, clinicians and researchers have been suddenly confronted with the difficulty of treatment provision and continuation of clinical trials without face-to-face contact. This predicament has resulted in the rapid adoption of telehealth methodologies.(1) Clinicians and researchers focused on obesity management have an additional need-- a remote way to measure weight. In this piece, we will describe electronic scales (e-scales) and provide guidance on how clinicians/researchers might best implement e-scales in their clinical practice or research studies to remotely measure weight.","Obesity (Silver Spring)","Krukowski, Rebecca A","Ross, Kathryn M","32339394"],"abstract":["With the COVID-19 pandemic, clinicians and researchers have been suddenly confronted with the difficulty of treatment provision and continuation of clinical trials without face-to-face contact. This predicament has resulted in the rapid adoption of telehealth methodologies.(1) Clinicians and researchers focused on obesity management have an additional need-- a remote way to measure weight. In this piece, we will describe electronic scales (e-scales) and provide guidance on how clinicians/researchers might best implement e-scales in their clinical practice or research studies to remotely measure weight."],"journal":"Obesity (Silver Spring)","authors":["Krukowski, Rebecca A","Ross, Kathryn M"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339394","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/oby.22851","keywords":["biomedical technology","body weight","clinical care","clinical trials","community health"],"weight":0,"_version_":1665264685615677440,"score":8.574329,"similar":[{"pmid":32207542,"title":"Action at a Distance: Geriatric Research during a Pandemic.","text":["Action at a Distance: Geriatric Research during a Pandemic.","BACKGROUND: \"Action at a distance\" may be the new norm for clinical researchers in the context of the COVID-19 pandemic that may require social distancing for the next 18 months. We must minimize face-to-face contact with vulnerable populations. But we must also persist, adapt, and help our older patients and study participants during the pandemic. METHODS: Clinical researchers have an obligation to help, and we can. Recommendations for clinical researchers working with older adults during the COVID-19 pandemic are discussed. RESULTS: Implement technology now: Minimize face-to-face contact with participants by utilizing digital tools, such as shifting to electronic informed consent and digital HIPAA-compliant tools such as e-mailed surveys or telehealth assessments. Assess the psychological and social impact of COVID-19: How are participants coping? What health or social behaviors have changed? How are they keeping up with current events? What are they doing to stay connected to their families, friends, and communities? Are their healthcare needs being met? Current studies should be adapted immediately to these ends. Mobilize research platforms for patient needs: Leverage our relationships with participants and rapidly deploy novel clinical engagement techniques such as digital tools to intervene remotely and reduce the negative effects of social isolation on our participants. Equip research staff with tangible resources, and provide timely population-specific health information to support patients and healthcare providers. CONCLUSIONS: We have an opportunity to make an impact on our older adult patients now as this pandemic continues to unfold. Above all, clinical researchers need to continue working, to help as many people as possible through the crisis.","J Am Geriatr Soc","Nicol, Ginger E","Piccirillo, Jay F","Mulsant, Benoit H","Lenze, Eric J","32207542"],"abstract":["BACKGROUND: \"Action at a distance\" may be the new norm for clinical researchers in the context of the COVID-19 pandemic that may require social distancing for the next 18 months. We must minimize face-to-face contact with vulnerable populations. But we must also persist, adapt, and help our older patients and study participants during the pandemic. METHODS: Clinical researchers have an obligation to help, and we can. Recommendations for clinical researchers working with older adults during the COVID-19 pandemic are discussed. RESULTS: Implement technology now: Minimize face-to-face contact with participants by utilizing digital tools, such as shifting to electronic informed consent and digital HIPAA-compliant tools such as e-mailed surveys or telehealth assessments. Assess the psychological and social impact of COVID-19: How are participants coping? What health or social behaviors have changed? How are they keeping up with current events? What are they doing to stay connected to their families, friends, and communities? Are their healthcare needs being met? Current studies should be adapted immediately to these ends. Mobilize research platforms for patient needs: Leverage our relationships with participants and rapidly deploy novel clinical engagement techniques such as digital tools to intervene remotely and reduce the negative effects of social isolation on our participants. Equip research staff with tangible resources, and provide timely population-specific health information to support patients and healthcare providers. CONCLUSIONS: We have an opportunity to make an impact on our older adult patients now as this pandemic continues to unfold. Above all, clinical researchers need to continue working, to help as many people as possible through the crisis."],"journal":"J Am Geriatr Soc","authors":["Nicol, Ginger E","Piccirillo, Jay F","Mulsant, Benoit H","Lenze, Eric J"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32207542","week":"202013|Mar 23 - Mar 29","doi":"10.1111/jgs.16443","keywords":["clinical research","mobile health","social isolation"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352133740658688,"score":221.76425},{"pmid":32312892,"title":"Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic.","text":["Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic.","The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has necessitated changes in cancer care delivery as resources are reallocated. Clinical trials and other research activities are inevitably impacted. Start-up activities for new trials may be deferred and recruitment suspended. For patients already enrolled however, there are challenges in continuing treatment on trial. Regulatory bodies have issued guidance on managing clinical trials during the pandemic, including contingency measures for remote study visits, delivery of investigational product and site monitoring visits. New cancer clinical trial practices during the SARS-CoV-2 pandemic include new risk assessment strategies, decentralized and remote trial co-ordination, data collection and delegation of specific therapeutic activities. This experience could provide evidence of more feasible and cost-effective methods for future clinical trial conduct.","Clin Cancer Res","Tan, Aaron C","Ashley, David M","Khasraw, Mustafa","32312892"],"abstract":["The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has necessitated changes in cancer care delivery as resources are reallocated. Clinical trials and other research activities are inevitably impacted. Start-up activities for new trials may be deferred and recruitment suspended. For patients already enrolled however, there are challenges in continuing treatment on trial. Regulatory bodies have issued guidance on managing clinical trials during the pandemic, including contingency measures for remote study visits, delivery of investigational product and site monitoring visits. New cancer clinical trial practices during the SARS-CoV-2 pandemic include new risk assessment strategies, decentralized and remote trial co-ordination, data collection and delegation of specific therapeutic activities. This experience could provide evidence of more feasible and cost-effective methods for future clinical trial conduct."],"journal":"Clin Cancer Res","authors":["Tan, Aaron C","Ashley, David M","Khasraw, Mustafa"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312892","week":"202017|Apr 20 - Apr 26","doi":"10.1158/1078-0432.CCR-20-1364","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520168235010,"score":206.18489},{"pmid":32294297,"title":"The Impact of COVID-19 on Bariatric Surgery: Re-Defining Psychosocial Care.","text":["The Impact of COVID-19 on Bariatric Surgery: Re-Defining Psychosocial Care.","The global outbreak of novel coronavirus disease (COVID-19) has had a tremendous psychological impact on individuals around the world. Individuals with obesity are susceptible to distress and psychological sequalae secondary to this pandemic, which can have detrimental effects on obesity management. In particular, individuals undergoing bariatric surgery could experience increased emotional distress resulting in increased eating psychopathology, mental health exacerbation and difficulties with self-management. Addressing these challenges requires novel approaches to re-defining psychosocial care before and after bariatric surgery. Emerging evidence suggests the remote delivery of care using virtual care models, including mobile and online modalities, could extend the reach of psychosocial services to individuals after bariatric surgery and mitigate weight regain or impairment in quality of life. Due to this pandemic, the rapid integration of virtual psychosocial care in bariatric surgery programs to address patients' needs will create new opportunities for clinical and implementation science research.","Obesity (Silver Spring)","Sockalingam, Sanjeev","Leung, Samantha E","Cassin, Stephanie E","32294297"],"abstract":["The global outbreak of novel coronavirus disease (COVID-19) has had a tremendous psychological impact on individuals around the world. Individuals with obesity are susceptible to distress and psychological sequalae secondary to this pandemic, which can have detrimental effects on obesity management. In particular, individuals undergoing bariatric surgery could experience increased emotional distress resulting in increased eating psychopathology, mental health exacerbation and difficulties with self-management. Addressing these challenges requires novel approaches to re-defining psychosocial care before and after bariatric surgery. Emerging evidence suggests the remote delivery of care using virtual care models, including mobile and online modalities, could extend the reach of psychosocial services to individuals after bariatric surgery and mitigate weight regain or impairment in quality of life. Due to this pandemic, the rapid integration of virtual psychosocial care in bariatric surgery programs to address patients' needs will create new opportunities for clinical and implementation science research."],"journal":"Obesity (Silver Spring)","authors":["Sockalingam, Sanjeev","Leung, Samantha E","Cassin, Stephanie E"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294297","week":"202016|Apr 13 - Apr 19","doi":"10.1002/oby.22836","source":"PubMed","weight":0,"_version_":1664636192726974464,"score":193.84158},{"pmid":32336578,"title":"Could telehealth help eye care practitioners adapt contact lens services during the COVID-19 pandemic?","text":["Could telehealth help eye care practitioners adapt contact lens services during the COVID-19 pandemic?","The COVID-19 pandemic has necessitated government-imposed restrictions on social interactions and travel. For many, the guidance has led to new ways of working, most notably a shift towards working remotely. While eye care practitioners (ECPs) may continue to provide urgent or emergency eye care, in many cases the travel restrictions present a unique challenge by preventing conventional face-to-face examination. Telephone triage provides a useful starting point for establishing at-risk and emergency patients; but patient examination is central to contact lens patient care. The indeterminate period over which conventional practice will be suspended, and the risk that resumption of 'normal' practice could be impeded by a potential secondary peak in COVID-19 cases, hastens the need for practitioners to adapt their delivery of eyecare. Specifically, it is prudent to reflect upon supportive evidence for more comprehensive approaches to teleoptometry in contact lens practice. Smartphone based ocular imaging is an area which has seen considerable growth, particularly for imaging the posterior eye. Smartphone imaging of the anterior eye requires additional specialised instrumentation unlikely to be available to patients at home. Further, there is only limited evidence for self-administered image capture. In general, digital photographs, are useful for detection of gross anterior eye changes, but subtle changes are less discernible. For the assessment of visual acuity, many electronic test charts have been validated for use by practitioners. Research into self-administered visual acuity measures remains limited. The absence of a comprehensive evidence base for teleoptometry limits ECPs, particularly during this pandemic. Knowledge gaps ought to be addressed to facilitate development of optometry specific evidence-based guidance for telecare. In particular, advances in ocular self-imaging could help move this field forwards.","Cont Lens Anterior Eye","Nagra, Manbir","Vianya-Estopa, Marta","Wolffsohn, James S","32336578"],"abstract":["The COVID-19 pandemic has necessitated government-imposed restrictions on social interactions and travel. For many, the guidance has led to new ways of working, most notably a shift towards working remotely. While eye care practitioners (ECPs) may continue to provide urgent or emergency eye care, in many cases the travel restrictions present a unique challenge by preventing conventional face-to-face examination. Telephone triage provides a useful starting point for establishing at-risk and emergency patients; but patient examination is central to contact lens patient care. The indeterminate period over which conventional practice will be suspended, and the risk that resumption of 'normal' practice could be impeded by a potential secondary peak in COVID-19 cases, hastens the need for practitioners to adapt their delivery of eyecare. Specifically, it is prudent to reflect upon supportive evidence for more comprehensive approaches to teleoptometry in contact lens practice. Smartphone based ocular imaging is an area which has seen considerable growth, particularly for imaging the posterior eye. Smartphone imaging of the anterior eye requires additional specialised instrumentation unlikely to be available to patients at home. Further, there is only limited evidence for self-administered image capture. In general, digital photographs, are useful for detection of gross anterior eye changes, but subtle changes are less discernible. For the assessment of visual acuity, many electronic test charts have been validated for use by practitioners. Research into self-administered visual acuity measures remains limited. The absence of a comprehensive evidence base for teleoptometry limits ECPs, particularly during this pandemic. Knowledge gaps ought to be addressed to facilitate development of optometry specific evidence-based guidance for telecare. In particular, advances in ocular self-imaging could help move this field forwards."],"journal":"Cont Lens Anterior Eye","authors":["Nagra, Manbir","Vianya-Estopa, Marta","Wolffsohn, James S"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336578","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.clae.2020.04.002","keywords":["anterior eye segment","covid-19","contact lenses","evidence based healthcare","telehealth","teleoptometry"],"topics":["Prevention"],"weight":1,"_version_":1665264685663911937,"score":169.17725},{"pmid":32235161,"title":"COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN.","text":["COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN.","INTRODUCTION: With the current COVID-19 pandemic, concerns have been raised about the risk to children with inflammatory bowel diseases (IBD). We aimed to collate global experience and provide provisional guidance for managing paediatric IBD (PIBD) in the era of COVID-19. METHODS: An electronic reporting system of children with IBD infected with SARS-CoV-2 has been circulated among 102 PIBD centres affiliated with the Porto and Interest-group of ESPGHAN. A survey has been completed by major PIBD centres in China and South-Korea to explore management during the pandemic. A third survey collected current practice of PIBD treatment. Finally guidance points for practice have been formulated and voted upon by 37 PIBD authors and Porto group members. RESULTS: Eight PIBD children had COVID-19 globally, all with mild infection without needing hospitalization despite treatment with immunomodulators and/or biologics. No cases have been reported in China and South Korea but biologic treatment has been delayed in 79 children, of whom 17 (22%) had exacerbation of their IBD. Among the Porto group members, face-to-face appointments were often replaced by remote consultations but almost all did not change current IBD treatment. Ten guidance points for clinicians caring for PIBD patients in epidemic areas have been endorsed with consensus rate of 92-100%. CONCLUSIONS: Preliminary data for PIBD patients during COVID-19 outbreak are reassuring. Standard IBD treatments including biologics should continue at present through the pandemic, especially in children who generally have more severe IBD course on one hand, and milder SARS-CoV-2 infection on the other.","J Pediatr Gastroenterol Nutr","Turner, Dan","Huang, Ying","Martin-de-Carpi, Javier","Aloi, Marina","Focht, Gili","Kang, Ben","Zhou, Ying","Sanchez, Cesar","Kappelman, Michael D","Uhlig, Holm H","Pujol-Muncunill, Gemma","Ledder, Oren","Lionetti, Paolo","Dias, Jorge Amil","Ruemmele, Frank M","Russell, Richard K","32235161"],"abstract":["INTRODUCTION: With the current COVID-19 pandemic, concerns have been raised about the risk to children with inflammatory bowel diseases (IBD). We aimed to collate global experience and provide provisional guidance for managing paediatric IBD (PIBD) in the era of COVID-19. METHODS: An electronic reporting system of children with IBD infected with SARS-CoV-2 has been circulated among 102 PIBD centres affiliated with the Porto and Interest-group of ESPGHAN. A survey has been completed by major PIBD centres in China and South-Korea to explore management during the pandemic. A third survey collected current practice of PIBD treatment. Finally guidance points for practice have been formulated and voted upon by 37 PIBD authors and Porto group members. RESULTS: Eight PIBD children had COVID-19 globally, all with mild infection without needing hospitalization despite treatment with immunomodulators and/or biologics. No cases have been reported in China and South Korea but biologic treatment has been delayed in 79 children, of whom 17 (22%) had exacerbation of their IBD. Among the Porto group members, face-to-face appointments were often replaced by remote consultations but almost all did not change current IBD treatment. Ten guidance points for clinicians caring for PIBD patients in epidemic areas have been endorsed with consensus rate of 92-100%. CONCLUSIONS: Preliminary data for PIBD patients during COVID-19 outbreak are reassuring. Standard IBD treatments including biologics should continue at present through the pandemic, especially in children who generally have more severe IBD course on one hand, and milder SARS-CoV-2 infection on the other."],"journal":"J Pediatr Gastroenterol Nutr","authors":["Turner, Dan","Huang, Ying","Martin-de-Carpi, Javier","Aloi, Marina","Focht, Gili","Kang, Ben","Zhou, Ying","Sanchez, Cesar","Kappelman, Michael D","Uhlig, Holm H","Pujol-Muncunill, Gemma","Ledder, Oren","Lionetti, Paolo","Dias, Jorge Amil","Ruemmele, Frank M","Russell, Richard K"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235161","week":"202014|Mar 30 - Apr 05","doi":"10.1097/MPG.0000000000002729","source":"PubMed","topics":["Treatment"],"weight":1,"locations":["China","South-Korea","China","South Korea"],"countries":["Korea, Republic of","China"],"countries_codes":["KOR|Korea, Republic of","CHN|China"],"_version_":1664638354176606208,"score":162.46968}]}